08/01/2026
The Department of Veterans Affairs on Thursday announced a clinical trial to test whether injectable semaglutide, a GLP-1 drug widely prescribed for diabetes and weight loss can also treat alcohol abuse, a longstanding problem in the military and veteran community.
Excessive drinking has steadily plagued military culture, and in some instances, it has been tolerated or normalized.
GLP-1s can dampen cravings and early research suggests they might help with alcoholism and even other substance abuse issues, at least in the short term.
Read more: https://abcnews.visitlink.me/M7y8cb